Table 2.
Meta-regression analysis for the risk of ischemic stroke after COVID-19 infection.
| Items | Coeff. | 95% CI | p |
|---|---|---|---|
| Age (years) | 0.002 | 0.105 to 0.154 | 0.001 |
| Male sex (%) | –0.012 | –0.059 to –0.028 | 0.01 |
| HT (%) | 0.007 | 0.006 to 0.009 | 0.001 |
| DM (%) | –0.016 | –0.039 to 0.006 | 0.16 |
| COPD (%) | –0.005 | –0.029 to 0.019 | 0.69 |
| CKD (%) | –0.015 | –0.051 to 0.019 | 0.37 |
| Obesity (%) | 0.005 | 0.014 to 0.025 | 0.002 |
| Cancer (%) | –0.041 | –0.100 to 0.018 | 0.17 |
| Follow-up length (months) | –0.045 | –0.047 to –0.137 | 0.003 |
CI: confidence interval; HT: arterial hypertension; DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease; CKD: chronic kidney disease.